Hedge Fund - Darwin Global Management

Keros Therapeutics Inc. (KROS) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q1 (2025-03-31) $0 0% 0 $11.61
2 2024 - Q4 (2024-12-31) $26,707,347 2.52% 1,687,135 $51.97
3 2024 - Q3 (2024-09-30) $88,483,117 7.19% 1,523,732 $49.39
4 2024 - Q2 (2024-06-30) $68,772,403 8% 1,525,902 $53.73
5 2024 - Q1 (2024-03-31) $95,059,890 12.65% 1,435,950 $59.30
6 2023 - Q4 (2023-12-31) $42,162,578 8.27% 1,060,427 $31.36
7 2023 - Q2 (2023-06-30) $0 0% 0 $43.84
8 2023 - Q1 (2023-03-31) $1,340,182 0.36% 31,386 $50.51
9 2022 - Q4 (2022-12-31) $20,578,107 12.81% 428,532 $46.71
10 2022 - Q1 (2022-03-31) $0 0% 0 $51.33
11 2021 - Q4 (2021-12-31) $6,524,000 0.99% 111,500 $49.87
12 2021 - Q3 (2021-09-30) $0 0% 0 $35.59
13 2021 - Q2 (2021-06-30) $4,425,000 0.71% 104,186 $54.17
14 2021 - Q1 (2021-03-31) $5,348,000 1.04% 86,887 $63.36

The displayed share prices are average quarterly stock market prices.